DOCSLIB.ORG

Clinical Content Data Points Dictionary

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Clinical Content Data Points Dictionary Abstracted Primary Childhood Cancer Diagnoses within Abstracted Diagnosis Groups Data Freeze: June 30, 2017 Broad Diagnosis Group (diaggrp) Diagnosis (diag) Acute lymphoblastic leukemia Acute Lymphoblastic Leukemia, B Lineage, Bone Marrow Acute Lymphoblastic Leukemia, B-Cell, Bone Marrow Acute Lymphoblastic Leukemia, B-Cell, Mature, Bone Marrow Acute Lymphoblastic Leukemia, B-Lineage, Transitional, Bone Marrow Acute Lymphoblastic Leukemia, Bone Marrow Acute Lymphoblastic Leukemia, Common , Bone Marrow Acute Lymphoblastic Leukemia, Common Pre B, Bone Marrow Acute Lymphoblastic Leukemia, Common, Early Pre B, Bone Marrow Acute Lymphoblastic Leukemia, Early B, Bone Marrow Acute Lymphoblastic Leukemia, Early Pre B, Bone Marrow Acute Lymphoblastic Leukemia, Early Pre B, Hematological Acute Lymphoblastic Leukemia, Early Pre-B, Atypical, Bone Marrow Acute Lymphoblastic Leukemia, Early T Cell Precursor, Bone Marrow Acute Lymphoblastic Leukemia, Mixed Early Pre B And Pre B, Bone Marrow Acute Lymphoblastic Leukemia, Mixed Pre B And Mature B, Bone Marrow Acute Lymphoblastic Leukemia, Non B, Non Pre B, Bone Marrow Acute Lymphoblastic Leukemia, Pre B And Pre B Transitional, Bone Marrow Acute Lymphoblastic Leukemia, Pre-B, Bone Marrow Acute Lymphoblastic Leukemia, Pre-T Cell, Bone Marrow Acute Lymphoblastic Leukemia, Progenitor B Cell, Bone Marrow Acute Lymphoblastic Leukemia, T-Cell, Bone Marrow Acute Lymphoblastic Leukemia, Transitional Pre B, Bone Marrow Acute Lymphoblastic Leukemia, Undifferentiated, Bone Marrow T Cell Large Granular Lymphocytic Leukemia, Bone Marrow Acute myeloid leukemia Acute Erythroleukemia, Fab M6, Bone Marrow Acute Histiocytic Leukemia Acute Megakaryoblastic Leukemia, Bone Marrow Acute Megakaryoblastic Leukemia, Fab M7, Bone Marrow Acute Monocytic Leukemia, Bone Marrow Acute Monocytic Leukemia, Fab M5, Bone Marrow Acute Myelocytic Leukemia, Bone Marrow Acute Myelocytic Leukemia, Differentiated, Bone Marrow Acute Myelocytic Leukemia, Undifferentiated, Bone Marrow Acute Myeloid Leukemia With 11q23/Mll Abnormalities, Bone Marrow Acute Myeloid Leukemia With Inv(16) Or T(16;16) [cbfbeta/Myh11], Bone Marrow (Rev. 13FEB19) Abstracted Primary Childhood Cancer Diagnoses within Abstracted Diagnosis Groups Data Freeze: June 30, 2017 Broad Diagnosis Group (diaggrp) Diagnosis (diag) Acute Myeloid Leukemia With Multilineage Dysplasia, With Prior Myelodysplastic Syndrome, Bone Marrow Acute Myeloid Leukemia With T(6;9)(P23;q34) Dek-Nup214, Bone Marrow Acute Myeloid Leukemia With T(8;21) (Q22;q22) [aml1/Eto], Bone Marrow Acute Myeloid Leukemia, Minimal Differentiation, Fab M0, Bone Marrow Acute Myeloid Leukemia, Nos, Bone Marrow Acute Myeloid Leukemia, With Maturation, Fab M2, Bone Marrow Acute Myeloid Leukemia, Without Maturation, Fab M1, Bone Marrow Acute Myelomonocytic Leukemia, Bone Marrow Acute Myelomonocytic Leukemia, Fab M4, Bone Marrow Acute Myelomonocytic Leukemia, Fab M4eo(With Abnormal Eosinophils), Bone Marrow Acute Myelomonocytic Leukemia, Fab M4eo, Bone Marrow Acute Promyelocytic Leukemia With T(15;17) [pml-Rara], Bone Marrow Acute Promyelocytic Leukemia, Bone Marrow Acute Promyelocytic Leukemia, Fab M3, Bone Marrow Blood disorder Hemophagocytic Lymphohistiocytosis, Bone Marrow Central nervous system (CNS) Astrocytoma, Anaplastic (Low Grade-Moderate), Tectum Astrocytoma, Anaplastic, Cerebrum Astrocytoma, Anaplastic, Frontal Lobe Astrocytoma, Anaplastic, Frontal Lobe, Left Astrocytoma, Anaplastic, Frontal Lobe, Right Astrocytoma, Anaplastic, Frontoparietal Area Astrocytoma, Anaplastic, Frontoparietal Lobe, Right Astrocytoma, Anaplastic, Hypothalamus Astrocytoma, Anaplastic, Parietal Lobe, Left Astrocytoma, Anaplastic, Posterior Fossa Astrocytoma, Anaplastic, Spinal Cord, Cervical Astrocytoma, Anaplastic, Temporal Lobe Astrocytoma, Anaplastic, Temporal Lobe, Left Astrocytoma, Anaplastic, Temporal Lobe, Right Astrocytoma, Anaplastic, Temporoparietoccipital Lobes, Right Astrocytoma, Anaplastic, Thalamus Astrocytoma, Brainstem Astrocytoma, Cerebellum Astrocytoma, Cervicomedullary Junction Astrocytoma, Diffuse, Medulla (Rev. 13FEB19) Abstracted Primary Childhood Cancer Diagnoses within Abstracted Diagnosis Groups Data Freeze: June 30, 2017 Broad Diagnosis Group (diaggrp) Diagnosis (diag) Astrocytoma, Diffuse, Parietal Lobe, Right Astrocytoma, Diffuse, Pons Astrocytoma, Diffuse, Temporal Lobe, Left Astrocytoma, Diffuse, Temporal Lobe, Right Astrocytoma, Diffuse, Thalamus, Left Astrocytoma, Diffuse, Thalamus, Right Astrocytoma, Dorsally Exophytic, Brainstem Astrocytoma, Exophytic, Brainstem Astrocytoma, Exophytic, Cervicomedullary Junction Astrocytoma, Fibrillary, Brainstem Astrocytoma, Fibrillary, Frontal Lobe, Left Astrocytoma, Fibrillary, Frontal Lobe, Right Astrocytoma, Fibrillary, Parietal Lobe, Right Astrocytoma, Fibrillary, Parieto-Occipital Lobe Astrocytoma, Fibrillary, Pons Astrocytoma, Fibrillary, Spinal Cord Astrocytoma, Fibrillary, Temporal Lobe, Left Astrocytoma, Fibrillary, Temporal Lobe, Right Astrocytoma, Fibrillary, Thalamus Astrocytoma, Fibrillary, Thalamus, Right Astrocytoma, Frontal Lobe, Generally Astrocytoma, Frontal Lobe, Left Astrocytoma, Gemistocytic, Frontoparetial Region, Left Astrocytoma, High-Grade Infiltrative With Astroblastomatous Component, Occipital Region, Right Astrocytoma, Hypothalamic Region Astrocytoma, Hypothalamus Astrocytoma, Juvenile Pilocytic, Brainstem Astrocytoma, Juvenile Pilocytic, Cerebellar Hemisphere, Right Astrocytoma, Juvenile Pilocytic, Cerebellar Peduncle Astrocytoma, Juvenile Pilocytic, Cerebellum Astrocytoma, Juvenile Pilocytic, Cerebellum, Left Astrocytoma, Juvenile Pilocytic, Cerebellum, Right Astrocytoma, Juvenile Pilocytic, Cervicomedullary Astrocytoma, Juvenile Pilocytic, Diencephalon, Right (Rev. 13FEB19) Abstracted Primary Childhood Cancer Diagnoses within Abstracted Diagnosis Groups Data Freeze: June 30, 2017 Broad Diagnosis Group (diaggrp) Diagnosis (diag) Astrocytoma, Juvenile Pilocytic, Exophytic, Brainstem Astrocytoma, Juvenile Pilocytic, Exophytic, Fourth Ventricle Astrocytoma, Juvenile Pilocytic, Exophytic, Medulla Astrocytoma, Juvenile Pilocytic, Exophytic, Posterior Fossa Astrocytoma, Juvenile Pilocytic, Exophytic, Tectum Astrocytoma, Juvenile Pilocytic, Fourth Ventricle Astrocytoma, Juvenile Pilocytic, Frontal Lobe Astrocytoma, Juvenile Pilocytic, Frontal Lobe, Right Astrocytoma, Juvenile Pilocytic, Grade 1, Posterior Fossa Astrocytoma, Juvenile Pilocytic, Hypothalamus Astrocytoma, Juvenile Pilocytic, Hypothalamus, Right Astrocytoma, Juvenile Pilocytic, Hypothalamus/Optic Chiasm Astrocytoma, Juvenile Pilocytic, Midbrain Astrocytoma, Juvenile Pilocytic, Midbrain, Left Astrocytoma, Juvenile Pilocytic, Midbrain, Right Astrocytoma, Juvenile Pilocytic, Occipital Lobe, Left Astrocytoma, Juvenile Pilocytic, Occipital Lobe, Right Astrocytoma, Juvenile Pilocytic, Optic Chiasm Astrocytoma, Juvenile Pilocytic, Optic Chiasm, Bilateral Astrocytoma, Juvenile Pilocytic, Parasellar Astrocytoma, Juvenile Pilocytic, Posterior Fossa Astrocytoma, Juvenile Pilocytic, Posterior Fossa, Right Astrocytoma, Juvenile Pilocytic, Spinal Cord Astrocytoma, Juvenile Pilocytic, Spinal Cord, Cervical Astrocytoma, Juvenile Pilocytic, Tectal Plate Astrocytoma, Juvenile Pilocytic, Temporal Lobe, Left Astrocytoma, Juvenile Pilocytic, Temporal Lobe, Right Astrocytoma, Juvenile Pilocytic, Thalamus Astrocytoma, Juvenile Pilocytic, Thalamus, Left Astrocytoma, Juvenile Pilocytic, Thalamus, Right Astrocytoma, Juvenile Pilocytic, Third Ventricle Astrocytoma, Juvenile Pilocytic, Thoracic Spinal Cord Astrocytoma, Juvenile Pilocytic, Vermis, Left Astrocytoma, Midbrain (Rev. 13FEB19) Abstracted Primary Childhood Cancer Diagnoses within Abstracted Diagnosis Groups Data Freeze: June 30, 2017 Broad Diagnosis Group (diaggrp) Diagnosis (diag) Astrocytoma, Midbrain (Tegmentum), Left Astrocytoma, Midbrain/Thalamus, Right Astrocytoma, Optic Chiasma Astrocytoma, Optic Nerve Astrocytoma, Optic Pathway Astrocytoma, Parietal Lobe Astrocytoma, Parietal Lobe, Right Astrocytoma, Pilocytic, Cerebellar Peduncle, Left Astrocytoma, Pilocytic, Contiguous Sites Astrocytoma, Pilocytic, Hypothalamic Region Astrocytoma, Pilocytic, Midbrain Astrocytoma, Pilocytic, Optic Nerve, Left Astrocytoma, Pilocytic, Parietal Region, Right Astrocytoma, Pilocytic, Pineal Region Astrocytoma, Pilomyxoid, Cerebellum Astrocytoma, Pilomyxoid, Hypothalamus Astrocytoma, Pilomyxoid, Pons Astrocytoma, Pineal Astrocytoma, Pons Astrocytoma, Posterior Fossa Astrocytoma, Retina, Left Astrocytoma, Spinal Cord Astrocytoma, Spinal Cord T10-T12 (Low Grade) Astrocytoma, Spinal Cord, Cervical Astrocytoma, Spinal Cord, Cervical Region Astrocytoma, Spinal Cord, Cervicothoracic Astrocytoma, Spinal Cord, Thoracic Astrocytoma, Subependymal Giant Cell, Ventricle Astrocytoma, Suprasellar Region Astrocytoma, Tegmentum Of Fourth Ventricle Astrocytoma, Temporal Lobe Astrocytoma, Temporal Lobe, Left Astrocytoma, Temporal Lobe, Right Astrocytoma, Temporoparietal Region (Rev. 13FEB19) Abstracted Primary Childhood Cancer Diagnoses within Abstracted Diagnosis Groups Data Freeze: June 30, 2017 Broad Diagnosis Group (diaggrp) Diagnosis (diag) Astrocytoma, Thalamic Region Astrocytoma, Thalamic Region, Right Astrocytoma, Thalamus Astrocytoma, Thalamus, Right Astroglial Tumor, Hypothalamus Atypical Teratoid Rhabdoid Tumor, Cerebellar Hemisphere Atypical Teratoid Rhabdoid Tumor, Cerebellar Pontine Angle, Left Atypical Teratoid Rhabdoid Tumor, Cerebellar Pontine Angle, Right Atypical Teratoid Rhabdoid Tumor, Fourth Ventricle Atypical Teratoid Rhabdoid Tumor, Frontal Lobe,
Load more

Recommended publications
  • Laparoscopic Longitudinal Pancreaticojejunostomy for Chronic Pancreatitis
    JOP. J Pancreas (Online) 2015 Sep 08; 16(5):438-443. REVIEW ARTICLE Laparoscopic Longitudinal Pancreaticojejunostomy for Chronic Pancreatitis Tamotsu Kuroki, Susumu Eguchi Department of Surgery, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan ABSTRACT function. Pancreatic ductal drainage is one of the most important factors for the management of chronic pancreatitis. A longitudinal pancreaticojejunostomyChronic pancreatitis is ischaracterized a simple and byradical severe surgical abdominal treatment pain for and pancreatic progressive ductal insufficiency drainage. However, of pancreatic in recent endocrine/exocrine years laparoscopic pancreatic procedures have developed rapidly, and reports concerning laparoscopic pancreatic resection including laparoscopic longitudinal for chronic pancreatitis compared with conventional open surgery are unclear. In this review, we note that laparoscopic longitudinal pancreaticojejunostomy ishave a technically increased feasible, in number. safe and Nevertheless, effective surgical the benefits procedure of inlaparoscopic selected patients longitudinal with chronic pancreaticojejunostomy pancreatitis. INTRODUCTION Laramée et al. [22] found that surgical drainage treatment was highly cost-effective compared to endoscopic In patients with chronic pancreatitis, severe recurrent drainage treatment for patients with obstructive chronic pancreatitis. debilitatingabdominal [1–7].pain Theand elevated functional pressure endocrine/exocrine in the pancreatic Laparoscopic surgery was
    [Show full text]
  • INDIVIDUAL SANITARY MEASURE Denmark Daniel Oestmann And
    DECISION MEMORANDUM— INDIVIDUAL SANITARY MEASURE Denmark Daniel Oestmann and Priya Kadam David Smith and Kevin Gillespie EQUIVALENCE REQUEST: Denmark requested an equivalence determination for an alternative post-mortem inspection i.e. visual inspection instead of palpation and incision of lung and liver and their associated lymph nodes of slaughtered market hogs. For purposes of determining equivalence, Danish market hogs are of the 220-240 pounds /six months of age range; the alternative post-mortem inspection procedure is not applicable to sows, boars, and roaster pigs. BACKGROUND: On December 16, 2008 in an FSIS-Denmark bilateral meeting a team of FSIS experts met and reviewed Denmark’s Supply Chain Inspection system, and presentations by Danish officials. The Supply Chain Inspection system allows inspection of market hogs raised under an integrated quality control program coupled with an on-site verification at slaughter establishments of visually inspected carcasses and organs to ensure that passed carcasses and parts are wholesome and not adulterated. As a part of this inspection system, on December 24, 2008, FSIS approved Denmark’s use of an alternative post- mortem inspection procedure omitting the incision of mandibular lymph nodes for market hogs used to detect granulomatous lymphadenitis which is mitigated through on-farm controls that are assessed and reported through government oversight when hogs come to slaughter. As a part of this Supply Chain Inspection system, in April 2010, Denmark proposed another alternate visual only post mortem inspection procedure, omitting the palpation of mesenteric lymph nodes of slaughtered market hogs used to detect granulomatous lymphadenitis is mitigated through on-farm controls that are assessed and reported through government oversight when hogs come to slaughter.
    [Show full text]
  • Bariatric Surgery in Adolescents: to Do Or Not to Do?
    children Review Bariatric Surgery in Adolescents: To Do or Not to Do? Valeria Calcaterra 1,2 , Hellas Cena 3,4 , Gloria Pelizzo 5,*, Debora Porri 3,4 , Corrado Regalbuto 6, Federica Vinci 6, Francesca Destro 5, Elettra Vestri 5, Elvira Verduci 2,7 , Alessandra Bosetti 2, Gianvincenzo Zuccotti 2,8 and Fatima Cody Stanford 9 1 Pediatric and Adolescent Unit, Department of Internal Medicine, University of Pavia, 27100 Pavia, Italy; [email protected] 2 Pediatric Department, “V. Buzzi” Children’s Hospital, 20154 Milan, Italy; [email protected] (E.V.); [email protected] (A.B.); [email protected] (G.Z.) 3 Clinical Nutrition and Dietetics Service, Unit of Internal Medicine and Endocrinology, ICS Maugeri IRCCS, 27100 Pavia, Italy; [email protected] (H.C.); [email protected] (D.P.) 4 Laboratory of Dietetics and Clinical Nutrition, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, 27100 Pavia, Italy 5 Pediatric Surgery Department, “V. Buzzi” Children’s Hospital, 20154 Milan, Italy; [email protected] (F.D.); [email protected] (E.V.) 6 Pediatric Unit, Fond. IRCCS Policlinico S. Matteo and University of Pavia, 27100 Pavia, Italy; [email protected] (C.R.); [email protected] (F.V.) 7 Department of Health Sciences, University of Milan, 20146 Milan, Italy 8 “L. Sacco” Department of Biomedical and Clinical Science, University of Milan, 20146 Milan, Italy 9 Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; [email protected] * Correspondence: [email protected] Abstract: Pediatric obesity is a multifaceted disease that can impact physical and mental health.
    [Show full text]
  • Clinical Practice Guideline for Limb Salvage Or Early Amputation
    Limb Salvage or Early Amputation Evidence-Based Clinical Practice Guideline Adopted by: The American Academy of Orthopaedic Surgeons Board of Directors December 6, 2019 Endorsed by: Please cite this guideline as: American Academy of Orthopaedic Surgeons. Limb Salvage or Early Amputation Evidence-Based Clinical Practice Guideline. https://www.aaos.org/globalassets/quality-and-practice-resources/dod/ lsa-cpg-final-draft-12-10-19.pdf Published December 6, 2019 View background material via the LSA CPG eAppendix Disclaimer This clinical practice guideline was developed by a physician volunteer clinical practice guideline development group based on a formal systematic review of the available scientific and clinical information and accepted approaches to treatment and/or diagnosis. This clinical practice guideline is not intended to be a fixed protocol, as some patients may require more or less treatment or different means of diagnosis. Clinical patients may not necessarily be the same as those found in a clinical trial. Patient care and treatment should always be based on a clinician’s independent medical judgment, given the individual patient’s specific clinical circumstances. Disclosure Requirement In accordance with AAOS policy, all individuals whose names appear as authors or contributors to this clinical practice guideline filed a disclosure statement as part of the submission process. All panel members provided full disclosure of potential conflicts of interest prior to voting on the recommendations contained within this clinical practice guideline. Funding Source This clinical practice guideline was funded exclusively through a research grant provided by the United States Department of Defense with no funding from outside commercial sources to support the development of this document.
    [Show full text]
  • The Subperitoneal Space and Peritoneal Cavity: Basic Concepts Harpreet K
    ª The Author(s) 2015. This article is published with Abdom Imaging (2015) 40:2710–2722 Abdominal open access at Springerlink.com DOI: 10.1007/s00261-015-0429-5 Published online: 26 May 2015 Imaging The subperitoneal space and peritoneal cavity: basic concepts Harpreet K. Pannu,1 Michael Oliphant2 1Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA 2Department of Radiology, Wake Forest University School of Medicine, Winston-Salem, NC, USA Abstract The peritoneum is analogous to the pleura which has a visceral layer covering lung and a parietal layer lining the The subperitoneal space and peritoneal cavity are two thoracic cavity. Similar to the pleural cavity, the peri- mutually exclusive spaces that are separated by the toneal cavity is visualized on imaging if it is abnormally peritoneum. Each is a single continuous space with in- distended by fluid, gas, or masses. terconnected regions. Disease can spread either within the subperitoneal space or within the peritoneal cavity to Location of the abdominal and pelvic organs distant sites in the abdomen and pelvis via these inter- connecting pathways. Disease can also cross the peri- There are two spaces in the abdomen and pelvis, the toneum to spread from the subperitoneal space to the peritoneal cavity (a potential space) and the subperi- peritoneal cavity or vice versa. toneal space, and these are separated by the peritoneum (Fig. 1). Regardless of the complexity of development in Key words: Subperitoneal space—Peritoneal the embryo, the subperitoneal space and the peritoneal cavity—Anatomy cavity remain separated from each other, and each re- mains a single continuous space (Figs.
    [Show full text]
  • California Tumor Tissue Registry Eighty-Eighth Semi
    CALIFORN IA TUMOR TISSUE REGISTRY EIGHTY-EIGHTH SEMI -ANNUAL SLIDE SEMINAR ON TUMORS OF THE CENTRAL NERVOUS SYSTEM MODERATOR: BERN W. SCHti THAUER, M. D. HEAD SECTION OF SURGICAL PATHOLOGY MAYO CLINIC PROFESSOR OF PATHOLOGY ROCHESTER, MINNESOTA CHAIRMAN: PHILIP VAN HALE, M. D. ASSOCIATE PATHOLOGIST HUNTINGTON MEMORIAL HOSP ITAL PASADENA, CALIFORNIA SUNDAY - JUNE 3, 1990 9:00 A.M. - 5:00 P.M. REGISTRATION: 7:30 A.M. SHERATON PLAZA LA REINA ~OTEL LOS ANGELES, CALIFORNIA (213) 642-1111 Please bring your protocol, but do not bring slides or microscopes to the meeting. CONTRIBUTOR: Bernd W. Scheithauer, M. 0. JUNE 1990 - CASE NO. 1 Rochester, Minnesota TISSUE FROM: Brain, left temporal parietal lobe ACCESSION NO. 26731 CLINICAL ABSTRACT : The patient is a 46 -year-old white ma le wh o experienced a head injury in 1960 but had no history of neurologic disturbances until 1982 at which time he noted the sudden onset of expressive aphasia. CT scan demonstrated a hypodense left temporoparietal lesion associated with a cyst. No enhancement was seen. - The patient elected to be medically observed over a five year interval, there being no intervention until symptoms interfered with his lifestyle. During that time he was maintained on phenobabital. The frequen cy of his partial complex seizures, which were characterized by expressive more than receptive aphasia, varied from one per month to six per week. They lasted from 1 to 30 minutes. No sensorimotor component was ever observed. Memory deficits followed the episodes. The first evidence of tumor enhancement was noted in 1984 and was seen to be somewhat more extensive in a 1986 study.
    [Show full text]
  • Primary Desmoid Tumor of the Small Bowel: a Case Report and Literature Review
    Open Access Case Report DOI: 10.7759/cureus.4915 Primary Desmoid Tumor of the Small Bowel: A Case Report and Literature Review Peter A. Ebeling 1 , Tristan Fun 1 , Katherine Beale 1 , Robert Cromer 2 , Jason W. Kempenich 1 1. Surgery, University of Texas Health Science Center at San Antonio, San Antonio, USA 2. Surgery, Keesler U.S. Air Force Medical Center, Biloxi, USA Corresponding author: Peter A. Ebeling, [email protected] Abstract Desmoid tumors, also known as aggressive fibromatosis, are fibromuscular neoplasms that arise from mesenchymal cell lines. They may occur in almost all soft tissue compartments. Primary desmoids of the small bowel are rare but potentially serious tumors presenting unique challenges to the general surgeon. We present one case of a 59-year-old man presenting with three months of abdominal distension secondary to a small bowel desmoid. Computed tomography of the abdomen showed an 18-cm mass in the mid-abdomen without obvious vital structure encasement. Percutaneous biopsy of the mass indicated a desmoid tumor. The patient underwent a successful elective exploratory laparotomy with resection and primary enteric anastomosis. Final pathology revealed the mass to be a primary desmoid of the small bowel. His post- operative course was uneventful. At two years after surgery, he is symptom free, and there is no evidence of disease recurrence. Due to the rare nature of primary small bowel desmoids, there are few specific care pathways outlined. This is a challenging pathology to treat that often requires a multidisciplinary team of surgical and medical oncologists. Categories: General Surgery, Oncology Keywords: desmoid, small bowel, resection, aggressive fibromatosis Introduction Desmoid tumors, also known as aggressive fibromatosis, are fibromuscular neoplasms that arise from mesenchymal cell lines.
    [Show full text]
  • Total Pancreatectomy-Autologous Islet Cell Transplantation (TP-AIT) for Chronic Pancreatitis – What Defines Success?
    CellR4 2015; 3 (2): e1536 Total Pancreatectomy-Autologous Islet Cell Transplantation (TP-AIT) For Chronic Pancreatitis – What Defines Success? C. S. Desai, K. M. Khan, W. X. Cui Medstar Georgetown Transplant Institute, Washington, DC, USA Corresponding Author : Wanxing Cui, MD, Ph.D; e-mail: [email protected] ABSTRACT 30 per 100,000 in United States according to the Na - Chronic pancreatitis is an inflammatory disease tional Institutes of Diabetes, Digestive and Kidney which is characterized by irreversible morpho - diseases (http://www.niddk.nih.gov). Patients with logic changes that typically causes pain and per - chronic pancreatitis suffer from debilitating pain, manent loss of the functions. The lack of good which progresses to significant narcotic medication treatment options for patients with chronic pan - requirement and deterioration in quality of life. Pa - creatitis is in part is related to any therapy need - tients can undergo multiple endoscopic and surgical ing to address the “3Ps” that are necessary for intervention procedures without significant success. this disorder.1) Pain relief, 2) Prevention of brit - In one report, pain recurs in over 50 percent of pa - tle diabetes mellitus and 3) Prevention of pan - tients after having endoscopic surgical procedures 1. creatic cancer. Total pancreatectomy and Total pancreatectomy may ameliorate the pain of autologous islet cell transplant (TP-AIT) does chronic pancreatitis however the resultant severe offer a definitive therapy while addressing these brittle diabetes makes this a less than desirable op - three; however there has not been a universal tion. Autologous islet cell transplant after total pan - uptake of this treatment to consider it the stan - createctomy (TP-AIT) gives patients with chronic dard of care due to it being considered highly in - pancreatitis the hope of pain relief and reduces the vasive and success being measured mainly by the potential for brittle diabetes.
    [Show full text]
  • Lumps and Bumps of the Abdominal Wall and Lumbar Region—Part 2: Beyond Hernias
    Published online: 2019-06-18 THIEME Review Article 19 Lumps and Bumps of the Abdominal Wall and Lumbar Region—Part 2: Beyond Hernias Sangoh Lee1 Catalin V. Ivan1 Sarah R. Hudson1 Tahir Hussain1 Suchi Gaba2 Ratan Verma1 1 1 Arumugam Rajesh James A. Stephenson 1Department of Radiology, University Hospitals of Leicester, Address for correspondence James A. Stephenson, MD, FRCR, Leicester General Hospital, Leicester, United Kingdom Department of Radiology, University Hospitals of Leicester, 2Department of Radiology, University Hospitals of North Midlands, ­­Leicester General Hospital, Leicester, LE5 4PW, United Kingdom Royal Stoke University Hospital, Stoke-on-Trent, United Kingdom (e-mail: [email protected]). J Gastrointestinal Abdominal Radiol ISGAR 2018;1:19–32 Abstract Abdominal masses can often clinically mimic hernias, especially when they are locat- ed close to hernial orifices. Imaging findings can be challenging and nonspecific Keywords with numerous differential diagnoses. We present a variety of pathology involving ► abdominal wall the abdominal wall and lumbar region, which were referred as possible hernias. This ► hernia demonstrates the wide-ranging pathology that can present as abdominal wall lesions ► mimics or mimics of hernias that the radiologist should be alert to. Introduction well-differentiated liposarcomas are histologically identical. The term “atypical lipoma” was coined by Evans et al in 1979 to An abdominal hernia occurs when an organ of a body ca vity describe well-differentiated liposarcoma of subcutaneous and 1 protrudes through a defect in the wall of that cavity. It is a 6 intramuscular layers. The World Health Organization (WHO) common condition with lifetime risk of developing a groin has further refined the definition by using atypical lipoma to hernia being estimated at 27% for men and 3% for women; it has describe subcutaneous lesions only and well- differentiated 2 thus been covered extensively in the literature.
    [Show full text]
  • New Jersey Chapter American College of Physicians
    NEW JERSEY CHAPTER AMERICAN COLLEGE OF PHYSICIANS ASSOCIATES ABSTRACT COMPETITION 2015 SUBMISSIONS 2015 Resident/Fellow Abstracts 1 1. ID CATEGORY NAME ADDITIONAL PROGRAM ABSTRACT AUTHORS 2. 295 Clinical Abed, Kareem Viren Vankawala MD Atlanticare Intrapulmonary Arteriovenous Malformation causing Recurrent Cerebral Emboli Vignette FACC; Qi Sun MD Regional Medical Ischemic strokes are mainly due to cardioembolic occlusion of small vessels, as well as large vessel thromboemboli. We describe a Center case of intrapulmonary A-V shunt as the etiology of an acute ischemic event. A 63 year old male with a past history of (Dominik supraventricular tachycardia and recurrent deep vein thrombosis; who has been non-compliant on Rivaroxaban, presents with Zampino) pleuritic chest pain and was found to have a right lower lobe pulmonary embolus. The deep vein thrombosis and pulmonary embolus were not significant enough to warrant ultrasound-enhanced thrombolysis by Ekosonic EndoWave Infusion Catheter System, and the patient was subsequently restarted on Rivaroxaban and discharged. The patient presented five days later with left arm tightness and was found to have multiple areas of punctuate infarction of both cerebellar hemispheres, more confluent within the right frontal lobe. Of note he was compliant at this time with Rivaroxaban. The patient was started on unfractionated heparin drip and subsequently admitted. On admission, his vital signs showed a blood pressure of 138/93, heart rate 65 bpm, and respiratory rate 16. Cardiopulmonary examination revealed regular rate and rhythm, without murmurs, rubs or gallops and his lungs were clear to auscultation. Neurologic examination revealed intact cranial nerves, preserved strength in all extremities, mild dysmetria in the left upper extremity and an NIH score of 1.
    [Show full text]
  • Hematopoietic and Lymphoid Neoplasm Coding Manual
    Hematopoietic and Lymphoid Neoplasm Coding Manual Effective with Cases Diagnosed 1/1/2010 and Forward Published August 2021 Editors: Jennifer Ruhl, MSHCA, RHIT, CCS, CTR, NCI SEER Margaret (Peggy) Adamo, BS, AAS, RHIT, CTR, NCI SEER Lois Dickie, CTR, NCI SEER Serban Negoita, MD, PhD, CTR, NCI SEER Suggested citation: Ruhl J, Adamo M, Dickie L., Negoita, S. (August 2021). Hematopoietic and Lymphoid Neoplasm Coding Manual. National Cancer Institute, Bethesda, MD, 2021. Hematopoietic and Lymphoid Neoplasm Coding Manual 1 In Appreciation NCI SEER gratefully acknowledges the dedicated work of Drs, Charles Platz and Graca Dores since the inception of the Hematopoietic project. They continue to provide support. We deeply appreciate their willingness to serve as advisors for the rules within this manual. The quality of this Hematopoietic project is directly related to their commitment. NCI SEER would also like to acknowledge the following individuals who provided input on the manual and/or the database. Their contributions are greatly appreciated. • Carolyn Callaghan, CTR (SEER Seattle Registry) • Tiffany Janes, CTR (SEER Seattle Registry) We would also like to give a special thanks to the following individuals at Information Management Services, Inc. (IMS) who provide us with document support and web development. • Suzanne Adams, BS, CTR • Ginger Carter, BA • Sean Brennan, BS • Paul Stephenson, BS • Jacob Tomlinson, BS Hematopoietic and Lymphoid Neoplasm Coding Manual 2 Dedication The Hematopoietic and Lymphoid Neoplasm Coding Manual (Heme manual) and the companion Hematopoietic and Lymphoid Neoplasm Database (Heme DB) are dedicated to the hard-working cancer registrars across the world who meticulously identify, abstract, and code cancer data.
    [Show full text]
  • Enteric Peripheral Neuroblastoma in a Calf
    NOTE Pathology Enteric peripheral neuroblastoma in a calf Yusuke SAKAI1)*, Masato HIYAMA2), Saya KAGIMOTO1), Yuki MITSUI1, Miko IMAIUMI1), Takeshi OKAYAMA3), Kaori HARADONO3), Masashi SAKURAI1) and Masahiro MORIMOTO1) 1)Laboratory of Veterinary Pathology, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi-shi, Yamaguchi 753-8515, Japan 2)Laboratory of Large Animal Clinical Medicine, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi-shi, Yamaguchi 753-8515, Japan 3)Tobu Large Animal Clinic, NOSAI Yamaguchi, 512-2 Kuhara, Shuto-cho, Iwakuni-shi, Yamaguchi 742-0417, Japan ABSTRACT. An 11-month-old female Japanese Black calf had showed chronic intestinal J. Vet. Med. Sci. symptoms. A large mass surrounding the colon wall that was continuous with the colon 81(6): 824–827, 2019 submucosa was surgically removed. After recurrence and euthanasia, a large mass in the colon region and metastatic masses in the omentum, liver, and lung were revealed at necropsy. doi: 10.1292/jvms.18-0450 Pleomorphic small cells proliferated in the mass and muscular layer of the colon. The cells were positively stained with anti-doublecortin (DCX), PGP9.5, nestin, and neuron specific enolase (NSE). Thus, the diagnosis of peripheral neuroblastoma was made. This is the first report of enteric Received: 31 July 2018 peripheral neuroblastoma in animals. Also, clear DCX staining signal suggested usefulness of DCX Accepted: 31 March 2019 immunohistochemistry to differentiate the neuroblastoma from other small cell tumors in cattle. Published online in J-STAGE: cattle, doublecortin, neuronal marker, neuronal neoplasm, peripheral neuroblastoma 9 April 2019 KEY WORDS: Neuroblastoma is an embryonal neuroectodermal neoplasm with limited neuronal differentiation that arises both in the central and peripheral nervous systems [12].
    [Show full text]